The Biotechnology Innovation Organization (BIO) has released the Industry Report Cards for all 50 states today at the BIO International Convention
Arizona holds its position at Tier II in number of biotech firms and Tier III in biotech employment
Investments in research and development (R&D) and programs encouraging private investments in Arizona innovator companies is the state’s greatest opportunity for driving future high-wage job growth in the life science sector.Continue reading
Bioscience industry contributing to U.S. economic growth and improving quality of life for patientsContinue reading
Results confirm accuracy of DecisionDx-Melanoma to identify recurrence risk; A second independent, prospective study confirms test accuracy
Please take a few minutes to log in to BIO’s FDA survey and provide feedback on your company’s interactions with FDA.Continue reading
The Clinical Data Interchange Standards Consortium (CDISC) and the Critical Path Institute (C-Path) announce the open availability of an updated CDISC Therapeutic Area (TA) Standard for tuberculosis (TB). The tuberculosis v2.0 standard is an updated version of the original TB v1.0 standard and includes new content focused on pediatrics and drug susceptibility testing.Continue reading
Systems Imagination (SII), a knowledge evolution company, announced today a partnership with Macrogen Corp. of Rockville, Maryland, the integrated genomic service provider and precision medicine biotechnology company.Continue reading
Dr. Glen Weiss is a Translational Physician Scientist (TPS) with a joint appointment at TGen and Cancer Treatment Centers of America. He is board certified in internal medicine and medical oncology. He is currently Co-Head of the Lung Cancer Unit and Clinical Associate Professor at TGen, Director of Clinical Research at Cancer Treatment Centers of America, and holds a Clinical Assistant Professor of Medicine appointment at the University of Arizona College of Medicine-Phoenix.Continue reading
PHOENIX, Ariz. (June 2, 2016) – VisionGate, Inc. today announced the appointment of Dr. Javier Zulueta as its Chief Medical Officer. A world-renowned pulmonologist, professor and 16-year Director of Pulmonary Service at the University Clinic of Navarra, the teaching hospital of Spain’s University of Navarra School of Medicine, Dr. Zulueta will provide expert counsel and oversight of VisionGate’s clinical collaborations and associated clinical trials in lung cancer early detection and chemoprevention therapy.Continue reading
Jennifer Barton is identifying biomarkers and creating optical imaging tools to screen for a form of cancer often called a “silent killer” of women.Continue reading
The Spring 2016 round of the Arizona Innovation Challenge (AIC) continues as the Arizona Commerce Authority (ACA) announced 10 finalists in its bi-annual business plan competition.